Ohio State Navbar

Research

Ginny L. Bumgardner, M.D., Ph.D.


395 W 12th Ave
Columbus, OH 43210

Phone: (614) 293-8545

Email: bumgardner.9@osu.edu

 

Current OSU Appointments

Professor, Transplant Surgery

Associate Dean, ADM-Medicine Administration

Physician, FGP-Transplant Surgery

 

Advising Narrative

Awarded the Spring 2004 undergraduate Research Scholarship from the College of Arts and Sciences Honors Committee.

Academic Advising

2007 - present Lori Fiessinger, The Ohio State University.
2008 - present Samiya Saklayen, The Ohio State University.
2013 - present Steven Elzein, The Ohio State University.
2014 - present Nahid Rashid, The Ohio State University.
2004 - 2005 Iram Qureshi, The Ohio State University.
2005 Megan Lutz, The Ohio State University.
2006 John Franklin, The Ohio State University.
2006 Jason Lather, The Ohio State University.
2006 Jonathan Bonchak, The Ohio State University.
2005 - 2007 Cassidy Schwab, The Ohio State University.
2014 - 2015 Dhriti Sooryakumar, The Ohio State University. Developing a surgical brigades program in Honduras
 

Licenses

1986 - present State of Minnesota: University of Minnesota
1992 - present American Board of Surgery: American Board of Surgery
 

Conferences

ROLE OF MACROPHAGES IN THE IMMUNE-RESPONSE TO HEPATOCYTES

MEMORY T-CELLS GENERATED INVITRO TO CLASS-I+, CLASS-II- HEPATOCYTES

INDIRECT ANTIGEN PRESENTATION OF HEPATOCYTE (HC) MHC CLASS-I ANTIGEN IN HC-SPONGE MATRIX ALLOGRAFTS

DETERMINANTS OF THE LENGTH OF SURVIVAL OF FIRST CADAVERIC (CAD) RENAL-TRANSPLANTS (TX)

THE ROLE OF MHC ANTIGENS AND ADHESION MOLECULES ON IN-VIVO CELLULAR IMMUNE-RESPONSE TO ALLOGENEIC HEPATOCYTES

Smoking and left ventricular hypertrophy (LVH) prior to renal transplantation (Tx) predict patient survival after Tx.

Role of CD8+ cells in rejection of allogeneic hepatocytes.

Prophylactic cholecystectomy is not indicated prior to kidney transplantation.

In vivo immune response to allogeneic hepatocytes

Single-center long-term results of renal transplantation for IgA nephropathy

Costimulation pathways in host immune responses to allogeneic hepatocytes.

In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model

Basiliximab and OKT3 in liver transplantation.

The optimal number of donor core biopsies to evaluate organs for liver transplantation

Rejection of allogeneic hepatocytes in hosts with long-term surviving MHC matched heart allografts

Histologic findings in human liver with no known liver disease: Implications for transplantation.

Independent roles for CD4(+) and CD8(+) T cells in initiating rejection of allogeneic hepatocytes.

Independent use of CD40L/CD40 costimulation by CD4(+) or CD8(+) T cells in response to allogeneic hepatocytes (allo HC)

Comparison of non-lipitor and lipitor therapy for treatment of hyperlipidemia in kidney transplant recipients.

Changes in the clinical characteristics of post transplant lymphoproliferative disease (PTLD) in kidney and simultaneous pancreas-kidney recipients (SPK).

IL-2r antibody induction with delayed Neoral therapy.

Randomized, prospective trial of prednisone withdrawal in stable renal transplant recipients.

Improved outcome in renal transplant recipients treated with simulect versus OKT3 induction.

Delayed cyclosporine administration following simulect induction does not increase acute rejection in renal transplant recipients.

Immediate renal allograft function following pulsatile preservation.

Tissue specific variation in host responses to alloantigenic stimuli.

Characteristics of CD40L/CD40 costimulation blockade in prevention of hepatocyte rejection.

Simultaneous acceptance of heart allografts and rejection of donor matched hepatocyte allografts in the same host.

Rejection responses to allogeneic hepatocytes by reconstituted scid mice, CD4 KO, and CD8 KO mice

Basiliximab vs OKT3 in primary simultaneous pancreas-kidney transplant recipients.

Basiliximab vs OKT3 in liver transplantation.

Differential use of costimulatory signals in CD4(+) versus CD8(+) T cell mediated immune hepatocellular injury.

Differential use of costimulatory signals in CD4(+) versus CD8(+) T cell mediated immune hepatocellular injury.

Targeting LFA-1-mediated signaling synergizes with CD40/CD40L costimulatory blockade to suppress both CD4- and CD8-dependent hepatocyte rejection

Cell transplant characteristics influence CD4(+) T cell alloimmune responses

Acceptance of immunogenic hepatocyte allografts under cover of donor specific transfusion and costimulatory blockade with anti-CD40L mAb requires host CD8+T cells.

Divergence of response to cellular transplants under cover of DST and anti-CD40L mAb

Long-term intrahepatic islet allograft acceptance is perturbed by local immune events

Longterm regulation of immunoresistant CD8+T cell mediated immune damage of liver parenchymal cells.

Targeting LFA-1 synergizes with CD40/CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection

Cell transplant characteristics influence CD4(+) T cell alloimmune responses

Long-term intrahepatic islet allograft acceptance is perturbed by local immune events

Divergence of response to cellular transplants under cover of DST and anti-CD40L mAb

Targeting LFA-1-mediated signaling synergizes with CD40/CD40L costimulatory blockade to suppress both CD4- and CD8-dependent hepatocyte rejection

Acceptance of immunogenic hepatocyte allografts under cover of donor specific transfusion and costimulatory blockade with anti-CD40L mAb requires host CD8+T cells.

Longterm regulation of immunoresistant CD8+T cell mediated immune damage of liver parenchymal cells.

Role of alloantibody in CD4(+) T cell dependent immune damage of hepatocytes.

Longterm regulation of CD8(+) T cells by short-term immunotherapy targeting LFA-1 and CD40/CD40L costimulation.

Critical role for CD8(+) T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade

Evidence for tissue-directed immune responses: Analysis of CD4-and CD8-dependent alloimmunity

Longterm regulation of CD8(+) T cells by short-term immunotherapy targeting LFA-1 and CD40/CD40L costimulation.

Role of alloantibody in CD4(+) T cell dependent immune damage of hepatocytes.

In vivo CD8+ T cell-mediated cytotoxic immune damage of allogeneic liver parenchymal cells develops in the presence or absence of CD4+ T cells

CD4(+) T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody

Steroid avoidance in liver transplantation.

Mechanisms of activation of (CD4-indepenedent) CD8-dependent immune responses to parenchymal cell allografts.

Mechanisms of immune regulation for (CD4-independent) CD8-dependent immune responses by short-term immunotherapy targeting LFA-1 and CD40/CD154 costimulation.

Targeting LFA-1 and CD154 suppresses the in vivo activation and development of cytolytic (CD4-independent) CD8(+) T cells

Mechanisms of activation of (CD4-indepenedent) CD8-dependent immune responses to parenchymal cell allografts.

Mechanisms of immune regulation for (CD4-independent) CD8-dependent immune responses by short-term immunotherapy targeting LFA-1 and CD40/CD154 costimulation.

Steroid avoidance in liver transplantation.

The assessment of damage to pancreatic islets using confocal microscopy and vital dyes

In vivo CD8+ T cell-mediated cytotoxic immune damage of allogeneic liver parenchymal cells develops in the presence or absence of CD4+ T cells

Activation and maturation of alloreactive CD4-independent, CD8(+) cytolytic T cells

Allogeneic liver parenchymal cells activate distinct subsets of destructive CD8+T cells

Allogeneic liver parenchymal cells activate distinct subsets of destructive CD8+T cells

A prospective study of steroid free, calcinurein inhibitor free maintenance immunosuppression based on rapamune/myfortic in kidney transplantation, an interim analysis.

Single center experience of PTLD after kidney and kidney/pancreas transplantation.

Kidney retransplantation using a rapamune based, steroid sparing immunosuppressive protocol.

The effects of obesity on renal transplant recipients.

Humoral immune damage of liver parenchymal cells is macrophage dependent.

Distinct allospecific CD8 CTL responses develop in the presence or absence of CD4(+) T Cells.

Differential requirement for host lymphoid tissue by CD4-Dependent and (CD4-Independent) CD8-Dependent rejection pathways.

Immunotherapy targeting CD154 and LFA-1 prevents hepatocyte rejection by primed CD8(+) T cells.

Kidney retransplantation using a rapamune based, steroid sparing immunosuppressive protocol.

A prospective study of steroid free, calcinurein inhibitor free maintenance immunosuppression based on rapamune/myfortic in kidney transplantation, an interim analysis.

The effects of obesity on renal transplant recipients.

Steroid free maintenance immunosuppression with rapamune and low dose neural in pancreas transplant recipients.

Humoral immune damage of liver parenchymal cells is macrophage dependent.

Single center experience of PTLD after kidney and kidney/pancreas transplantation.

Distinct allospecific CD8 CTL responses develop in the presence or absence of CD4(+) T Cells.

Immunotherapy targeting CD154 and LFA-1 prevents hepatocyte rejection by primed CD8(+) T cells.

Differential requirement for host lymphoid tissue by CD4-Dependent and (CD4-Independent) CD8-Dependent rejection pathways.

Distinct CD8-dependent cytotoxic effector mechanisms mature in CD4-sufficient and CD4-deficient immune conditions

A prospective study of steroid free, calcineurin inhibitor free maintenance immunosuppression based on rapamune/myfortic in kidney transplantation

Targeting LFA-1 inhibits CD8-Mediated in vivo cytotoxic effector function in sensitized recipients.

CD4(+) T cell-mediated help directed towards CD8(+) T cells is not required at the time of transplantation

Long term outcome of steroid free maintenance immunosuppression with sirolimus and low dose cyclosporine in primary kidney transplantation

Critical role of effector macrophages in mediating alloantibody mediated immune injury

Distinct CD8-dependent cytotoxic effector mechanisms mature in CD4-sufficient and CD4-deficient immune conditions

Long term outcome of steroid free maintenance immunosuppression with sirolimus and low dose cyclosporine in primary kidney transplantation

A prospective study of steroid free, calcineurin inhibitor free maintenance immunosuppression based on rapamune/myfortic in kidney transplantation

The Murine Liver Immune Environment Promotes Potent Alloreactive CD8(+) T Cell Activation and Effector Function.

The Murine Liver Immune Environment Promotes Potent Alloreactive CD8(+) T Cell Activation and Effector Function.

The Outcome of Simultaneous Pancreas-Kidney Transplantation from Older Donor.

Monitoring EBV Infection among Seromismatch Adult Renal Transplant Recipients

CD8(+) T Cells Critically Influence Alloantibody Isotype Profiles after Liver Cell Transplantation

CD8(+) T Cells Display TNF-alpha and/or FasL Cytotoxic Effector Mechanisms In Vivo Which Are Critically Influenced by CD4(+) T Cells

CD8(+) T Cells Display TNF-alpha and/or FasL Cytotoxic Effector Mechanisms In Vivo Which Are Critically Influenced by CD4(+) T Cells

CD8(+) T Cells Critically Influence Alloantibody Isotype Profiles after Liver Cell Transplantation

The Outcome of Percutaneous Nephrostomy Drainage and Ureteral Stenting for Treatment of Urological Complications after Transplantation.

Macrophage Mediated Alloantibody-Dependent Hepatocytotoxicity Is Fc gamma RI, Fc gamma RIII, and Contact-Dependent

Alloprimed CD8(+) T Cells Eliminate Alloprimed IgG1-Producing B Cells through Perforin- and FasL-Dependent Mechanisms

Rapamycin Treatment Is Associated with Reduced Death and Graft Loss after Kidney Transplantation

Influence of BMI and Age on Simultaneous Kidney-Pancreas Recipients

Novel NKT Cell-Mediated Help for Alloantibody Production.

Pediatric Donors for Simultaneous Pancreas-Kidney Transplant (SPKT)

Novel NKT Cell-Mediated Help for Alloantibody Production.

Pediatric Donors for Simultaneous Pancreas-Kidney Transplant (SPKT).

Donors at Age Extremes for Simultaneous Pancreas-Kidney Transplant (SPKT)

Calcineurin (CNI) Exposure Reduces the Risk of Post-Transplant DSA After Deceased Donor Kidney Transplantation

Marked Suppression of Posttransplant Alloantibody Production and Primed B cell Function In Vivo by mTOR Inhibition Compared to Calcineurin Inhibition

Sirolimus Based Maintenance Immunosuppression in Pancreas Transplant Recipients

 

Degrees

1979 B.S., College of William and Mary

1983 M.D., University of Virginia School of Medicine

1994 Ph.D., University of Minnesota

 

Editorial Activities

1994 - present Transplantation
1996 - present Mayo Clinic Proceedings
1996 - present Kidney International
1996 - present Clinical Transplantation
1998 - present Hepatology
2000 - present American Journal of Transplantation
2000 - present Journal of Gastroenterology and Hepatology
2001 - 2008 Transplantation
2003 - present Nephron Clinical Practice
2004 - present Current Surgery
2004 - present American Journal of Kidney Diseases
2005 - present Liver Transplantation
2005 - present Blood
2006 - present Liver International
2006 - present American Journal of Transplantation
2007 - present Pediatric Transplantation
2007 - present Journal of Immunology
2013 - present Journal of Immunology
2014 - present Liver Transplantation
 

Honors

1976 Freshman Scholastic Achievement Award (Alpha Lambda Delta).
1977 Phi Sigma (Biology Honor Society).
1978 Phi Beta Kappa.
1978 Omicron Delta Kappa (Scholastic Honor Society).
1978 Mortar Board.
1982 Alpha Omega Alpha.
1983 Lange Award (Scholastic Achievement Award). American Medical Women's Association.
1989 Surgical David Gaviser Research Award.
1995 - present American College of Surgeons Faculty Fellowship Award.
1996 - present American Digestive Health Foundation, Miles & Shirley Fiterman Foundation.
1997 - present American Digestive Health Foundation/AGA Industry Research Scholar Award.
1997 - present American Digestive Health Foundation Basic Science Research Award.
1997 - present American Society of Transplant Physicians Roche Investigator Award.
2001 - present Research Award.
2002 - present American Diabetes Association Research Award.
2003 - present American Society of Transplant Surgeons Midlevel Faculty Research Award.
2004 - present Roche Organ Transplant Research Foundation Award.
2005 - present OSU College of Medicine & Department of Surgery’s “Excellence in Teaching Award”.
2005 - 2006 America's Best Doctors.
2005 - 2014 Best Doctor for Central Ohio. Best Doctor.
2006 - 2007 America's Best Doctors.
2007 - 2008 America's Best Doctors. U.S. News & World Report.
2010 - present Faculty Award. The Landacre Honor Society.
2013 - present Best Doctors in America List. US News and World Report.
2013 - present 2013 OSU Patient Satisfaction Top 10% Providers. The Ohio State University Wexner Medical Center.
2014 - present OSU Courage to Teach Award. The Ohio State University.
2016 - present 2016 OSU Patient Satisfaction Ranked Top 10% Providers. The Ohio State University.
2016 - present Distinguished Undergraduate Research Mentor Award. The Ohio State University.
 

Journal Articles

.

"DUODENAL SEGMENT-ASSOCIATED COMPLICATIONS FOLLOWING COMBINED KIDNEY-PANCREAS TRANSPLANTATION." TRANSPLANTATION PROCEEDINGS. Vol. 25, no. 3. (June 1993.): -.

"Risk factors of long-term survivals in combined kidney/pancreas transplantation: A multivariate analysis of 259 recipients." TRANSPLANTATION PROCEEDINGS. Vol. 27, no. 6. (December 1995.): -.

"Outcome of combined kidney/pancreas transplantation in recipients with coronary artery disease." TRANSPLANTATION PROCEEDINGS. Vol. 27, no. 6. (December 1995.): -.

"High intravesical pressures and related urologic complications in simultaneous kidney pancreas transplant recipients." TRANSPLANTATION PROCEEDINGS. Vol. 27, no. 6. (December 1995.): -.

"Pulsatile preservation in renal transplantation." TRANSPLANTATION PROCEEDINGS. Vol. 29, no. 8. (December 1997.): -.

"Impact of intra-abdominal fluid collections following simultaneous pancreas-kidney transplantation on graft and patient loss." TRANSPLANTATION PROCEEDINGS. Vol. 30, no. 2. (March 1998.): -.

"Increased incidence of gastrointestinal surgical complications in renal transplant recipients with polycystic kidney disease." TRANSPLANTATION. Vol. 67, no. 2. (January 1999.): -.

"Magnetic resonance angiography for preoperative evaluation of potential kidney donors." JOURNAL OF SURGICAL RESEARCH. Vol. 120, no. 2. (August 2004.): -.

"Steroid-free maintenance immunosuppression with Rapamune and low-dose Neoral in pancreas transplant recipients." TRANSPLANTATION. Vol. 84, no. 9. (November 2007.): -.

"Monitoring infection with Epstein-Barr virus among seromismatch adult renal transplant recipients." American Journal of Transplantation. Vol. 11, no. 5. (May 2011.): -.

. -.

.

 

Reference Works

March 1908 ."" .
January 1988 Cahill DR, Johnson R, Cunningham TR, Bumgardner GL, Ascher NL."Effects of irradiation on DTH initiated by helper T cell clone" . : A1841
January 1988 Chen S, Bumgardner GL, Ascher NL."The antigenicity of mouse hepatocytes (HCS) is abrogated by preincubation of HCS with anti-class I antibody" . : A467
January 1988 Bumgardner GL, Chen S, Fasola C, Ascher NL."Culture of murine hepatocytes (HCS) does not alter in vitro antigenicity" . : A467
January 1989 Bumgardner GL, Payne WD, Matas AJ, Cahill D, Chen S, Ascher NL."In vivo immunogenicity of MHC class I+ hepatocytes" . : A1126
January 1993 McMullan DM*, Bumgardner GL, Hayes-Lattin B, Osorio RW, Ascher NL."Preoperative serum arginase level as a predictor of rejection in human orthotopic liver recipients" . : 338A
January 1993 McMullan DM*, Bumgardner GL, Hayes-Lattin B, Osorio RW, Ascher NL."Arginase as an indicator of acute vs. ongoing hepatocellular damage" . : 338A
January 1993 Bumgardner GL, McMullan DM*, Lin A, Konstantinides FN, Cerra FB, Fasola C."The role of arginase in liver immunity" . : 211A
January 1995 Li J, Bumgardner GL."The role of MHC antigens and adhesion molecules on in vivo cellular immune responses to allogeneic hepatocytes" . : 447A
January 1996 Bumgardner GL, Heininger MB, Li J, Xia D, Parker-Thornberg J, Ferguson RM."Role of CD8+ cells in rejection of allogeneic hepatocytes" . : 490A
January 1998 Pelletier RP, Cosio F, Henry ML, Bumgardner GL, Davies EA, Elkhammas EA, Ferguson RM."Acute rejection following renal transplantation. Evidence that severity is the best predictor of subsequent graft survival time" . : 543-552
January 1999 Bumgardner GL, Henry ML, Elkhammas EA, Sherman T, Bowen G, Davies EA, Pelletier RP, Jones L, Ferguson RM."Early graft function after in situ LR followed by backtable organ perfusion with U W" . : s653
January 1999 Bumgardner GL, Gao D, Li J, Orosz CG."Independent use of CD40L/CD40 costimulation by CD4+ or CD8+ T cells in response to allogeneic hepatocytes (allo HC)" . : S606
January 1999 Gao D, Li J, Orosz CG, Bumgardner GL."Independent Roles for CD4+ and CD8+ T Cells in Initiating Rejection of Allogeneic Hepatocytes" . : s122
January 1999 Elkhammas EA, Henry ML, Carmona MM, Bumgardner GL, Pelletier RP, Ferguson RM."Simulect and delayed neoral in liver and kidney/pancreas transplantation" . : s632
January 1999 Bumgardner GL, Ramos E, Vincenti F."Results of Zenapax for prevention of acute rejection in recipients with delayed graft function" . : S562
January 1999 Pelletier RP, Davies EA, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM."Changes in the clinical characteristics of post transplant lymphoproliferative disease (PTLD) in kidney and simultaneous pancreas-kidney recipients (SPK)" . : s621
January 1999 Tranovich J, Salter L, Bumgardner GL, Baker P, Fardal P, Frankel WL."The optimal number of donor core biopsies to evaluate organs for liver transplantation" .
January 1999 Tranovich J, Salter L, Bumgardner GL, Baker P, Fardal P, Frankel WL."Histologic findings in human livers with no known liver disease: Implications for transplantation" .
January 1999 Schlossberg M, Bumgardner GL, Henry ML, Elkhammas EA, Pelletier RP, Davies EA, Ferguson RM."Comparison of non-lipitor and lipitor therapy for treatment of hyperlipidemia in kidney transplant recipients" . : S618
January 1999 Li J, Gao D, Wakely E, Orosz CG, Bumgardner GL."Rejection of allogeneic hepatocytes in hosts with longterm surviving MHC matched heart allografts" . : s73
January 1999 Henry ML, Pelletier RP, Elkhammas EA, Bumgardner GL, Davies EA, Ferguson RM."IL- 2r antibody induction with delayed neoral therapy" . : s619
January 2000 Henry ML, Tso P, Elkhammas EA, Davies EA, Pelletier RP, Bumgardner GL, Ferguson RM."Immediate renal allograft function following pulsatile preservation" . : s335
January 2000 Bumgardner GL, Li J, Gao D, Orosz CG."Simultaneous acceptance of heart allografts and rejection of donor matched hepatocyte allografts in the same host" . : s224
January 2000 Gao D, Li J, Orosz CG, Bumgardner GL."Tissue specific variation in host responses to alloantigenic stimuli" . : s358
January 2000 Gao D, Li J, Orosz CG, Bumgardner GL.."Characteristics of CD40L/CD40 costimulation blockade in prevention of hepatocyte rejection" . : s284
January 2000 Pelletier RP, Davies EA, Elkhammas EA, Bumgardner GL, Henry ML, Ferguson RM.."Randomized prospective trial of prednisone withdrawal in stable renal transplant recipients." . : s167
January 2000 Pelletier RP, Davies EA, Elkhammas EA, Bumgardner GL, Henry ML, Ferguson RM.."Improved outcome in renal transplant recipients treated with Simulect versus OKT3 induction." . : s157
January 2000 Pelletier RP, Bumgardner GL, Davies EA, Elkhammas EA, Henry ML, Ferguson RM."Delayed cyclosporine administration following Simulect induction does not increase acute rejection in renal transplant recipients" . : s158
January 2000 Elkhammas EA, Henry ML, Demirag A, Carmona MM, Bumgardner GL, Pelletier RP, Ferguson RM."Basiliximab vs OKT3 in primary simultaneous pancreas-kidney transplant recipients." . : s407
January 2000 Elkhammas EA, Henry ML, Demirag A, Carmona MM, Bumgardner GL, Pelletier RP, Ferguson RM."Basiliximab vs OKT3 in liver transplantation" . : s167
January 2001 Salvemini P, Gao D, Orosz CG, Bumgardner GL."Alloantibody as an effector mechanism for CD4+ T cell initiated hepatocyte rejection" . : 237
January 2001 Gao D, Salvemini P, Orosz CG, Bumgardner GL."Indefinite survival of allogeneic hepatocytes promoted by DST and anti-CD40L mAb." . : 263
January 2002 Rajab A, Pelletier RP, Bumgardner GL, Henry ML, Ferguson RM, Elkhammas EA."Enteric conversion after pancreas transplantation" . : S565
January 2002 Lunsford KE, Gao D, Orosz CG, Bumgardner GL."Tissue directed immune responses" . : S599
January 2002 Lunsford KE, Gao D, Bumgardner GL."Disparate immune responses evoked by donor matched islets vs hepatocellular allografts" . : A286
January 2002 Gao D, Wang Y, Godell C, Bumgardner GL."Differential use of costimulatory signals in CD4+ and CD8+ T Cell Mediated Immune Hepatocellular Injury" . : S210A
January 2002 Elkhammas EA, Sadeq AM, Bumgardner GL, Pelletier RP, Ferguson RM, Henry ML."Kidney/pancreas transplantation with the use of OKT3 or simulect for induction therapy" . : S711
January 2002 Wang Y, Gao D, Bumgardner GL."A role for LFA-1 in CD8+ T cell mediated hepatocyte rejection" . : S209
January 2002 Lunsford KE, Ferketich A, Bumgardner GL."Lipid levels in combined pancreas and kidney transplant recipients in a single center" . : A625
January 2002 Rajab A, Henry ML, Elkhammas EA, Bumgardner GL, Davies EA, Ferguson RP, Pelletier RP."Prospective comparison of hand-assisted laparoscopic versus open living donor nephrectomy" . : S441
January 2002 Gao D, Wang Y, Millward L, Kiefaber M, Salvemini P, Bumgardner GL."Immune characteristics of CD4+ T cell mediated hepatocyte rejection" . : S345
January 2002 Wang Y, Gao D, Bumgardner GL."Targeting LFA-1 suppresses CD8+ T cell mediated hepatocyte rejection" . : 340
January 2002 Rajab A, Henry ML, Elkhammas EA, Bumgardner GL, Davies EA, Ferguson RM, Pelletier RP."Hand-assisted laparoscopic right donor nephrectomy" . : S440
January 2002 Lunsford KE, Gao D, Orosz CG, Bumgardner GL."Donor-matched hepatocytes perturb allograft acceptance in islet but not heart acceptor mice" . : 446
January 2002 Gao D, Wang Y, Millward L, Kiefaber M, Salvemini P, Bumgardner GL."Effector mechanisms in CD4+ T cell mediated hepatocyte rejection" . : 450
January 2003 Lunsford KE, Gao D, Bumgardner GL."Divergence of response to cellular transplants under cover of DST and anti-CD40L mAbs" . : 162
January 2003 Godell CM, Lunsford KE, Wang Y, Gao D, Bumgardner GL."Targeting LFA-1 mediated signaling synergizes with CD40/CD40L costimulatory blockade to suppress both CD4- and CD8-dependent hepatocyte rejection" . : 150
January 2003 Lunsford KE, Gao D, Bumgardner GL."Acceptance of immunogeneic hepatocyte allografts under cover of donor specific transfusion and costimulatory blockade with anti-CD40L mAb requires host CD8+ T cells" . : 48A
January 2003 Lunsford KE, Gao D, and Bumgardner GL."Divergence of response to cellular transplants under cover of DST and anti-CD40L mAbs" . : 162
January 2003 Lunsford KE, Gao D, Hummel A, Bumgardner GL."Longterm regulation of immunoresistant CD8+ T cell mediated immune damage of liver parenchymal cells" . : 78A
January 2003 Lunsford KE, Gao D, Bumgardner GL."Donor specific transfusion and costimulation blockade produces opposite effects on alloreactive CD4+ T cell immune responses" . : S404
January 2003 Lunsford KE, Wang Y, Gao D, Bumgardner GL."Tissue-associated factors influence CD4+ T cell alloimmune responses." . : S536
January 2003 Lunsford KE, Gao D, Bumgardner GL."Local immune events interfere with longterm islet allograft acceptance" . : A431
January 2003 Lunsford KE, Elkhammas E, Henry ML, Davies EA, Pelletier RP, Rajab A, Ferguson RM, Ferketich A, Bumgardner GL."Comparison of lipid profiles in kidney and combined kidney and pancreas transplant recipients at a single center" . : S380
January 2003 Godell CM, Lunsford KE, Wang Y, Gao D, Bumgardner GL."Anti-LFA-1 mAb synergizes with costimulation blockade to suppress both CD4- and CD8-dependent hepatocyte rejection" . : S407
January 2003 Henry ML, Pelletier RP, Elkhammas EA, Davies EA, Rajab A, Bumgardner GL, Ferguson RM."Pulsatile preservation is associated with a low incidence of delayed graft function" . : S428
January 2003 Bumgardner GL, Henry ML, Elkhammas E, Davies EA, Pelletier RP, Rajab A, Ferguson RM."Early function of cadaveric kidney, pancreas, and liver transplants perfused using in situ lr followed by backtable organ perfusion with UW" . : S557
January 2003 Rajab A, Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM."Magnetic resonance angiography for preoperative evaluation of live kidney donors" . : S493
January 2004 Lunsford KE, Horne PH, Wang Y, Gao D, Eiring AM, Bumgardner GL."Role of alloantibody in CD4+ T cell dependent immune damage of hepatocytes" . : 457
January 2004 Lunsford KE, Eiring AM, Koester MA, Gao D, Bumgardner GL."Longterm regulation of CD8+ T cells by short-term costimulation" . : 330
January 2005 Horne PH, Lunsford KE, Koester MA, Walker JP, Eiring AM, Bumgardner GL."In Vivo CD8+ T cell-mediated cytotoxic immune damage of allogeneic liver parenchymal cells develops in the presence or absence of CD4+ T cells" . : 196A
January 2005 Lunsford KE, Koester MA, Eiring AM, Horne PH, Bumgardner GL."Mechanisms of immune regulation for (CD4-independent) CD8-dependent immune responses by short-term immunotherapy targeting LFA-1 and CD40/CD154 costimulation" . : 364
January 2005 Lunsford KE, Koester MA, Horne PH, Eiring AM, Qureshi Z, Bumgardner GL."Mechanisms of activation of (CD8-independent) CD8-dependent immune responses to parenchymal cell allografts" . : 268
January 2005 Elkhammas E, Henry ML, Ferguson RM, Bumgardner GL, Pelletier RP, Rajab A."Steroid avoidance in simultaneous liver transplantation" . : 475
January 2006 Horne PH, Lunsford KE, Koester MA, Walker JP, Eiring AM, Bumgardner GL."Allogeneic liver parenchymal cells initiate the development of in vivo CD8-dependent allospecific cytotoxicity in the presence or absence of CD4+ T cells" . : 1028
January 2006 Koester MA, Walker JP, Horne PH, Lunsford KE, Eiring AM, Bumgardner GL."Immune microenvironment promotes divergence of alloimmune pathways in response to hepatocellular allografts" . : 217
January 2006 Horne, PH, Koester MA, Lunsford KE, Dziema HL, Jayashankar K, Bumgardner GL."Allogeneic Liver Parenchymal Cells Activate Distinct Subsets of Destructive CD8+ Cells" . : 400A-401A
January 2007 Horne PH, Lunsford KE, Fisher M, Bumgardner GL."Differential Requirement for Host Lymphoid Tissue by CD4-dependent and (CD4-independent) CD8-dependent Rejection Pathways" . : 412
January 2007 Horne PH, Koester MA, Jayashankar K, Schwab CS, Dziema HL, Bumgardner GL."Humoral Immune Damage of Liver Parenchyma Cells is Macrophage Dependent" . : 497
January 2007 Horne PH, Koester MA, Jayashankar K, Bumgardner GL."Distinct Allospecific CD8+ CTL Responses Develop in the Presence or Absence of CD4+ T Cells" . : 323
January 2007 Ferguson RM, Henry ML, Pelletier RP, GL Bumgardner, Rajab A."Comparison of Myfortic with Cellcept as the Primary Switch Agent Utilized in a Rapamune Reduced-dose Neoral Steroid-free Maintenance Protocol in Renal Transplantation" . : 569
May 2008 Rajab A, Pelletier RP, Henry ML, Bumgardner GL, Elkhammas EA, Ferguson RM."Long Term Outcome of Steroid Free Maintenance Immunosuppression with Sirolimus and Low Dose Cyclosporine in Primary Kidney Transplantation" . : 587
May 2008 Zimmerer JM, Horne PH, Fisher MG, Jayashankar K, Bumgardner GL."Distinct CD8-Dependent Cytotoxic Effector Mechanisms Mature in CD4-Sufficient and CD4-Deficient Immune Conditions" . : 622
May 2008 Zimmerer JM, Horne PH, Fisher M, Lunsford KE, Nadasdy G, Nadasdy T, Rooijen NV, Bumgardner GL."Critical Role of Effector Macrophages in Mediating Alloantibody Mediated Immune Injury" . : 487
May 2008 Rajab A, Pelletier RP, Henry ML, Elkhammas EA, Bumgardner GL, Ferguson RM."A Prospective Study of Steroid Free, Calcineurin Inhibitor Free Maintenance Immunosuppression Based on Rapamune/Myfortic in Kidney Transplantation" . : 585
May 2008 Zimmerer JM, Horne PH, Jayashankar K, Fisher M, Bumgardner GL."Targeting LFA-1 Inhibits CD8-Mediated In Vivo Cytotoxic Effector Function in Sensitized Recipients" . : 230
May 2008 Zimmerer JM, Fiessinger LA, Bumgardner GL."CD4+ T Cell-Mediated Help Directed towards CD8+ T Cells Is Not Required at the Time of Transplantation" . : 622

Presentations

Allospecific delayed hypersensitivity (DTH) reactions to both strong and weak alloantigens can be evoked by pure cloned helper T cells

Immunosuppressive effects of murine liver cytosol in vivo

The effects of murine liver cytosol on the development of humoral immunity

Posttransplant pregnancy at a single center

In vitro generated memory cells to MHC Class I+ Class II- hepatocytes

Immunosuppressive factors in hepatocyte and liver cytosol

Cell subsets responding to MHC Class I+ Class II- hepatocytes

Role of hepatocyte (HC) class I antigen shedding in the development of cytotoxic T lymphocytes (CTLs) in vitro and in vivo

Cell subsets responding to purified hepatocytes (HC) in vitro and in vivo and evidence for indirect antigen presentation

A comparison of OKT3 vs. Minnesota anti lymphocyte globulin (MALG) induction therapy in liver transplants

Indirect Antigen Presentation of Hepatocyte MHC Class I Antigen

Immunology of Transplantation

Experimental Hepatocyte Transplantation

Overview of Liver Transplantation

Comparison of in vivo MHC antigen and adhesion molecule expression in murine liver under normal and inflammatory conditions

Simultaneous Kidney/Pancreas Transplantation: Assessment and Management of Complications

Management of ureteral complications in renal transplant patients using percutaneous nephrostomy

Infectious complications in combined kidney/pancreas transplantation

Determinants of long-term survivals in combined kidney/pancreas transplantation

Coronary artery disease is not a contraindication in combined kidney/pancreas transplantation

A comparison of DST- vs. CSA-based immunosuppression with 10 year follow-up.

Pulsatile preservation - Results after 1,000 kidneys

Pathways of Signal Transduction in Lymphocytes

Management of biliary complications

Variables related to the donor renal graft predict its function and survival. However, the recipient race cancels the predictive effect of donor factors

Obesity is a significant risk factor for decreased long-term graft survival after combined pancreas and renal transplantation

High serum cholesterol (Chol) levels enhance acute cyclosporine nephrotoxicity (CsAtox)

Effect ofhyperlipidemia on long-term graft and patient survival after kidney transplantation

Coronary artery disease is not a contraindication in combined kidney/pancreas transplantation

A randomized prospective trial of OG 37-325 vs. cyclosporine in cadaveric renal transplantationprospective trial of OG 37-325 vs. cyclosporine in cadaveric renal transplantation

Immunology of Transplantation

Obesity is a significant risk factor for decreased long-term graft survival after combined pancreas and renal transplantation

Liver and Pancreas Transplantation

Liver and Pancreas Transplantation

Comparison of serum lipids between diabetic kidney transplant and combined pancreas kidney transplant patients

Outcome of liver transplants with positive flow cytometry cross match

Effect of immunotherapy directed at adhesion molecules ICAM-1 and VCAM-1 on cellular immune responses to allogeneic hepatocytes

Pulsatile preservation: The 1400 kidney experience of a single institution

Pre-transplant blood pressure levels correlate with post-transplant blood pressure and with renal allograft survival in African American recipients

Obesity is a significant risk factor for decreased long term graft survival after renal transplantation

Left ventricular hypertrophy pre-transplant predicts patient survival after renal transplantation

Elevated urine collagen IV levels correlate with the severity of acute renal transplant rejection

Efficacy of anti-ICAM immunotherapy in abrogating parenchymal cell (hepatocyte) immunogenicity

Comparison of serum lipids between recipients of combined pancreas kidney transplants vs. kidney transplant alone in diabetic and nondiabetic patients

Pulsatile preservation: The 1400 kidney experience of a single institution

Outcome of liver transplants with positive flow cytometry cross match

Efficacy of anti-ICAM-1 immunotherapy in abrogating parenchymal cell (hepatocyte) immunogenicity in vivo

Determinants of long term survivals in combined kidney/pancreas transplantation. A review of 260 recipients

Antibody Induction-New Protocols

The impact of intra-abdominal fluid collections following simultaneous kidney/pancreas transplantation on early graft and patient loss

Outcome of enteric conversion of pancreas transplantation with bladder drainage

Immunology & Immunosuppressive Drugs

Economic impact of acute rejection in primary cadaveric kidney transplant recipients

Cholecystectomy posttransplant is well tolerated

Immunology of Transplantation

Experimental Hepatocyte Transplantation

Transplant Immunology

Antibody Induction-New Protocols

Outcome of 300 consecutive kidney/pancreas transplants

Immunology of Transplantation

Time on dialysis prior to renal transplantation correlates with patient survival post-tx

Success of operative intervention after combined pancreas kidney transplant for postoperative peripancreatic infection

Renal allograft survival in recipients of combined kidney-pancreas transplants

Posttransplant hyperlipidemia does not correlate with atherosclerotic complications after kidney transplant

Outcome of combined pancreas and kidney transplant from young and older organ donors

Mycophenolate mofetil decreases the acute rejection rate and delays the occurrence of first rejection in renal transplantation

Longterm allograft function after pregnancy in kidney transplant recipients

In vivo immunogenicity of allogeneic purified hepatocytes in a murine hepatocyte transplant model

Evidence that the intensity of acute rejection, independent of rejection number, predicts the rate of graft loss in kidney allograft recipients

Correlates of recurrent disease and graft loss from recurrent disease after kidney transplantation for IGA nephropathy

Combined kidney/pancreas transplantation comparison of mycophenolate mofetil vs. Azathioprine

Cellular mediators of hepatocellular allograft rejection

Analysis of complications in obese living kidney donors

A prospective randomized trial of neoral and cellcept with and without OKT3 induction

Results of combined pancreas and kidney transplant from young and older cadaveric organ donors.

Outcome of 300 consecutive kidney/pancreas transplants.

In vivo immune responses to allogeneic hepatocytes (HC) in a murine hepatocyte transplant (HCTx) model

Impact of intra-abdominal fluid collections following simultaneous kidney/pancreas (SPK) transplantation on early graft and patient loss.

Immunology and Transplantation

Immunogenicity of purified allogeneic liver cells and lack of immune privilege in the host liver

Combined kidney/pancreas transplantation (KPT): comparison of mycophenolate mofetil (MMF) vs. Azathioprine (AZA)

Cell subsets responding to purified allogeneic liver parenchymal cells

Transplantation

Hepatocyte Alloantigenicity

Mycophenolate mofetil decreases the acute rejection rate and delays the occurrence of first rejection in renal transplantation

IL2r Inhibition

Hepatocyte transplantation for hypercholesterolemia in APO E knockout mice

Fulminant Hepatic Failure

Outcome of 300 consecutive kidney/pancreas transplants

The older renal transplant recipient: advantage or disadvantage of decreased clinical immune responsiveness

T cell directed immunotherapy and hepatocyte transplantation

Low-dose angiotensin converting enzyme inhibitors (ACEi) are safe and effective in reducing proteinuria (UPROT) in renal allograft recipients

Hierarchy of T cell responses to allogeneic hepatocytes

De novo focal glomerulosclerosis (FGS) in renal allografts: relationship to total serum cholesterol (CHOL) concentration

Clinical and prognostic implications of the diagnosis of focal renal allograft infarction (INF) by biopsy

Antibody induction in the current era

Acute rejection (AR) is strongly associated with some forms of chronic allograft nephropathy (CN) but not with others

A prospective randomized trial of neoral and cellcept with and without OKT3 induction

Tolerance induced by heart allografts does not protect donor-matched hepatocytes from rejection

Costimulation pathways operative in host immune responses to allogeneic hepatocytes

Unusual patterns of alloimmune responses evoked by hepatocytes

Transplant Immunology

Transplant Immunology

Basic Immunology

Two independent pathways initiating rejection of allogeneic hepatocytes

Tolerance induced by heart allografts does not protect MHC matched hepatocytes from rejection

Oral Session 6: Tolerance Induction

Analysis of CD40L/CD40 costimulation in host immune responses to allogeneic hepatocytes

A new perspective on mechanisms of acute rejection: allogeneic hepatocytes initiate co-dominant independent CD4+ and CD8+ T cell mediated rejection

Immunology and Transplant

Transplantation I

Tolerance induced by heart allografts does not protect MHC matched hepatocytes from rejection

Rejection of allogeneic hepatocytes by independent co-dominant pathways

Results of Zenapax for prevention of acute rejection in recipients with delayed graft function

Recurrent Disease after Kidney Transplantation

Molecular Exploration in Transplant Immunology

Independent use of CD40L/CD40 Costimulation by CD4+ or CD8+ T cells in response to allogeneic hepatocytes

Early graft function after in situ LR followed by backtable organ perfusion with U W.

Three year outcome of the Phase III Clinical Trials with Daclizumab

Results of Zenapax for prevention of acute rejection in recipients with delayed graft function

Outcomes of Interventions for Postoperative Peripancreatic Infections in Pancreas Kidney Transplants

Organ Donation and Transplantation

Assessment of renal dysfunction

Cytomegalovirus and Transplantation

A functional model of hepatocyte transplantation

Basic Immunology and Experimental Design

Bone Marrow/GVHD, Cell Transplant

Role of costimulatory blockade for hepatocyte transplantation

Variation in host immune responses to donor matched heart, islet, or hepatocyte allografts

Simultaneous acceptance of FVB/N heart allografts and rejection of FVB/N hepatocyte allografts in C67BL/6 hosts

Effect of CD40L/CD40 costimulation blockade on host immune responses to allogeneic hepatocytes

Transplant Rejection

Perturbance of allograft acceptance by co-transplantation with donor-matched hepatocytes in islet but not heart acceptor mice

End Stage Renal Disease and Kidney Transplantation

Tissue Distinct Immune Responses

Indefinite survival of allogeneic hepatocytes promoted by DST and anti-CD40L mAb

Alloantibody as an effector mechanism for CD4+ T cell initiated hepatocyte rejection

Towards a better understanding of aggressive (CD4+ independent) CD8+ T cell alloimmune responses in vivo

Donor matched islet and hepatocellular allografts evoke disparate immune responses

Women Networking in Transplant Research

Targeting LFA-1 suppresses CD8+ T cell mediate hepatocyte rejection

Effector mechanisms in CD4+ T cell mediated hepatocyte rejection

Donor-matched hepatocytes perturb allograft acceptance in islet but not heart acceptor mice

Concurrent polar MHC-matched alloimmune responses

Immune characteristics of CD4+ T cell mediated hepatocyte rejection

A role for LFA-1 in CD8+ T cell mediated hepatocyte rejection

Tissue-associated factors influence CD4+ T cell alloimmune responses

Pulsatile preservation is associated with a low incidence of delayed graft function

Local immune events interfere with longterm islet allograft acceptance

Early function of cadaveric kidney, pancreas, and liver transplants perfused using in situ lr followed by backtable organ perfusion with UW

Donor specific transfusion and costimulation blockade produces opposite effects on alloreactive CD4+ T cell immune responses

Comparison of lipid profiles in kidney and combined kidney and pancreas transplant recipients at a single center

Anti-LFA-1 mAb synergizes with costimulation blockade to suppress both CD4- and CD8-dependent hepatocyte rejection

Transplant Immunology

Transplantation in the Modern Era

Costimulation Blockade Resistant Transplant Rejection

Local immune events interfere with longterm islet allograft acceptance

Transplantation in the Modern Era

Costimulation Blockade Resistant Transplant Rejection

Clinical and Experimental Cell Transplantation

Transplant Immunology

Patient Access to Replacement Therapy for Diabetes

Evaluation of the Living Kidney Donor

Role of alloantibody in CD4+ T cell dependent allogeneic hepatocyte rejection

Cell transplantation and Xenotransplantation

Tissue specific characteristics determine the pattern of the allograft rejection response

Host CD8+ T cells are required for induction of hepatocyte allograft acceptance under cover of donor specific transfusion (DST) and costimulatory blockade with anti-CD40L mAb

Clinical and Experimental Cell Transplantation

“Risk and implications of nephrolithiasis and infections,� “Cancer in the donor and the future risk of cancer,� AND “Surgical Risks,�

Transplant Immunosuppressive Agents

The Future of Cell Transplantation

Transplantation

Transplantation

Pre-Transplant Evaluation of Patients for Transplantation & Anatomy of Kidney and Kidney Pancreas Transplantation

Liver Transplantation: Surgical Aspects and Post-operative Complications

Transplantation

Revisiting Transplant Immunosuppression: Plans for the Next Decade

Clinical and Experimental Cell Transplantation

Transplantation

Pre-Transplant Evaluation of Patients for Transplantation & Anatomy of Kidney and Kidney Pancreas Transplantation

Mechanisms of immune regulation of CD8-dependent immune responses by short-term immunotherapy targeting LFA-1 and CD40/CD154 costimulation

Impact of host microenvironment upon immune responses elicited by hepatocellular allografts

Establishment of a gene transfer system in primary hepatocytes in suspension

Clinical and Experimental Cell Transplantation

Transplantation

Liver Transplantation: Surgical Aspects and Post-operative Complications

Islet Cell and Stem Cell

Genomics and Proteomics in Transplantation

Longterm regulation of CD8+ T cells by short-term immunotherapy targeting LFA-1 and CD40/CD40L costimulation

The Assessment of Damage to Pancreatic Islets Using Confocal Microscopy and Vital Dyes

Steroid avoidance in simultaneous pancreas-kidney transplantation

Ethical Issues in Clinical Transplantation

Mechanisms of immune regulation of CD8-dependent immune responses by short-term immunotherapy targeting LFA-1 and CD40/CD154 costimulation

Career Choices to be made by the MD PhD graduate

CD8+ T cells in Transplantation: Friend or Foe

Challenges in Kidney Transplantation

Long-term outcome of simultaneous pancreas-kidney (SPK) transplantation from older donors

Immune microenvironment promotes divergence of alloimmune pathways in response to hepatocellular allografts

Allogeneic liver parenchymal cells initiate the development of in vivo CD8-dependent allospecific cytotoxicity in the presence or absence of CD4+ T cells

Bioartificial Liver Devices

Liver

Bioartificial Liver Devices

Extracorporeal Liver Support as a Bridge to Hepatic Transplantation

Patient Centered Research Education for Medical Students.

Urine Cytology Screening for BK Nephropathy after Kidney Transplantation

Comparison of Myfortic with Cellcept as the Primary Switch Agent Utilized in a Rapamune Reduced-dose Neoral Steroid-free Maintenance Protocol in Renal Transplantation

The Masters of Medical Science Program: A Mechanism for Training the Future Leaders in Surgery

Pre-transplant Evaluation of the Kidney Pancreas Recipient

Clinical Medicine and Biomedical Research

Oral and Poster Presentations

IL-4-Dependent, IgG1-Dominant Allogeneic Antibody Production is Regulated by CD8+ T Cells in a Transplant Model

It's Gonna Be a Bright, Bright Sunshiny Day: How to Restore the Luster Soapbox Session

Summary of structure of HHMI Med-into-Grad program and how clinical experience is integrated into the program

Intersection between Innate and Humoral Immunity

Expanding Clinical Opportunities for PhD Students in Biomedical Sciences

CD8+ T Cell Regulation of Posttransplant Alloantibody

Education of Surgeon Scientists- Future Leaders of Surgical Innovation

Bench to Bedside: Early Results of Immune Profile Emerging Before Detection of De Novo Humoral Alloimmunity in Kidney Transplant Recipients

Recipient Selection and Evaluation- Kidney

Pediatric kidney transplantation.

Pregnancy in the renal transplant recipient.

Pregnancy and kidney transplantation.

[Hepatic transplantation].

Challenges in Liver Transplantation.

Responder T-cell subsets and antigenic stimulus in mixed lymphocyte-hepatocyte culture.

Pregnancy after kidney transplantation.

Pregnancy in lung transplant recipients.

Pregnancy and liver transplantation.

Organ transplantation.

Biopsy Proven Rejection (BPR) and Adverse Reactions (AR) with Induction Therapy Using Rabbit Antithymocyte Globulin (rATG) and Steroid-Free Maintenance Immunosuppression in Renal Transplant Recipients (RTx)

 

Professional Activities

1997 - present University Seed Grant.
1999 - present NIH Ad Hoc RFA (Hepatitis C). National Institutes of Health.
1999 - present Adhoc Review Committee on HepatitisC RFA, NIH NIDDK.
2003 - present Adhoc Review Committee on R01 Clinical Trials, NIH, NIDDK.
2003 - present ASTS- Novartis Fellowship Award.
2003 - present AST Reproductive Issues in Transplant Recipients Consensus Conference. Bethesda, MD.
2003 - present Consensus Conference on the Medical Evaluation of the Living Donor; "Risk and implications of nephrolithiasis and infections", "Cancer in the donor and the future risk of cancer" AND "Surgical Risks". Dallas, TX.
2004 - present American Board of Surgery Certifying (oral) Examination. Cincinnati, OH.
2004 - present National Institutes of Health.
2004 - present Ad Hoc TTT (Tumor, Transplant and Tolerance) Study Section. National Institutes of Health.
2004 - present NIH, TTT study section, Adhoc Member.
2004 - present NIH Special Emphasis Panel Reviewer on R01 and K23 Clinical Trials, NIH, NIDDK.
2005 - present OSU Roessler Scholarship Grant Reviewer.
2005 - present ASTS-reviewer for ASTS Collaborative Scientist Award.
2005 - present NIH, TTT study section, Adhoc Member.
2006 - present Professor Conference with PGY 4s & 5s on "Liver".
2006 - present NIH, Special Emphasis Panel, NCRR, Islet Cell Resource Center Grants.
2006 - present ASTS-Chair of Review Committee for ASTS-Wyeth MidLevel Faculty Research Award and Co-chair of ASTS Fellowship Award.
2007 - present Raines Priming Grant project, Australia.
2007 - present NIH, Special Emphasis Panel, NonHuman Primate Kidney/Islet Transplantation Tolerance.
2007 - present Comprehensive Cancer Program T32 training grants.
2007 - present ASTS-Co-chair Review Committee for ASTS-Wyeth Midlevel and ASTS Fellowship awards.
2008 - present PGY4 & 5 Professor Conference. Columbus, OH.
2008 - present OSU AOA medical student research awards.
2008 - present Davis/Bremer Grant Reviewer.
2008 - present Department of Surgery Annual Research Conference.
2009 - present Landacre Honor Society Induction Ceremony, Speaker. Columbus, OH.
2009 - present Med III Student Lecture, "Transplantation". Columbus, OH.
2009 - present 10th Annual Great Lakes Immunology Forum. Cleveland, OH.
2009 - present 8th Annual OSUMC Research Day.
2009 - present 8th Annual OSUMC research Day. Columbus, OH.
2009 - present OSU AOA Medical Student Research Awards.
2009 - present Med III Student Lecture, "Transplantion". Columbus, OH.
2009 - present LiteracyStudies @ OSU-Expanding Literacy Studies Conference.
2009 - present Med III Student Lecture, "Transplantation". Columbus, OH.
2009 - present Masters of Medical Science Program (PGY1s & PGY2s) Lecture. Columbus, OH.
2010 - present Talk to PGY1-3s on Research Projects; Diadactics Session on DOS Research Day. Columbus, OH.
2010 - present Postdoc Fellowship Panel Discussion, Panel Discussion on Postdoc Fellowship and Career Development Proposals. Columbus, OH.
2010 - present Med III Student Lecture "Transplantation". Columbus, OH.
2010 - present Integrated Biomedical Graduate Program Recruitment: Discussion on Research Opportunities. Columbus, OH.
2010 - present "NIH Career Development Grant Funding Opportunities for PhD and MD Scientists". Columbus, OH.
2011 - present 10th Annual OSUMC Research Day. Columbus, OH.
2011 - present "Preparing Your Oral Presentation for DOS Annual Research Conference". Columbus, OH.
2011 - present Med into Grad Scholars Program, 2011 Annual Meeting. Columbus, OH.
2011 - present Liver transplant Plenary II, AASLD 2011 The Liver Meeting. AASLD. San Francisco, CA.
2011 - present LiteracyStudies@OSU Winter Program- Literacy in Science. Columbus, OH.
2011 - present Thomas E. Starzl transplant Surgery State-of-the-Art Lecture "Tolerance and Memory", AASLD 2011 The liver Meeting. AASLD. San Francisco, CA.
2011 - present Medical Student Research Program Orientation. Columbus, OH.
2011 - present First Year Pulmonary/Critical Care Fellows Introduction. Columbus, OH.
2011 - present Plenary Session, Joint Plenary and Awards, 2011 American Transplant Congress. Philadelphia, PA.
2011 - present 2011 Liver Transplantation SIG program, "Crash Course on Genomics-and How it Can Benefit Your Patients and Your Career." AASLD 2011 The Liver Meeting. AASLD. San Francisco, CA.
1994 - 1996 Medical Research Development Fund.
2002 Mock NIH Study Session at the American College of Surgeons sponsored Young Surgical Investigator's Conference. organized by the ACS Surgical Research and Education Committee. Leesburg, VA.
1995 - 2009 National Kidney Foundation of Ohio.